FG directs states to halt vaccination halfway - Newstrends
Connect with us

Health

FG directs states to halt vaccination halfway

Published

on

-Bauchi, Benue comply as AstraZeneca vaccine shortage looms

-Remaining doses will be reserved for second jabs – Minister

The Federal Government has asked all the states administering the COVID-19 vaccine to stop the exercise the moment they use half of the doses allocated to them.

The National Primary Health Care Development Agency, Dr Faisal Shuaibu, asked all the states to suspend vaccination when they reach half of the doses delivered to them.

This implies that a state that was given 100,000 doses would have to halt the vaccine rollout once the doses hit 50,000 in order for those who have received their first jab to be able to complete their vaccination.

The move, it was learnt, had become necessary due to a possible delay in the supply of the next batch of the AstraZeneca vaccines, which could affect the availability of the vaccine for a second jab for those who have taken the first.

The shortage of the AstraZeneca vaccine in the international market is caused by a surge in the demand by the European Union and a new policy by India which manufactures the vaccine. India had said last week that it would prioritise domestic vaccination for its over 1.2 billion citizens, thereby causing a shortage in developing nations like Nigeria.

Confirming the development to one of our correspondents who made an enquiry on the matter, the Minister of State for Health, Dr Olorunnimbe Mamora, said states were asked to stop vaccination halfway until more vaccines arrive because it was the smartest thing to do since it is a double-dose vaccine.

Mamora said, “On the issue of stopping at half doses, we thought this is what wisdom dictates because in a situation where we seem to be in short supply, it stands to good reason to ensure that those who have had their first dose should be given the opportunity of having the second dose.

“It is better to have a pool of people who have received full vaccination rather than just do it halfway for everybody, which I think would not be the best in the circumstance. And you are not really covered if you have your full dosage.”

When asked when Nigerians should expect more vaccines, Mamora said he could not say because it is currently a ‘sellers’ market’.

He, however, said Nigeria was already having talks with other parties including Russia, which is producing the Sputnik V vaccine.

The minister stated, “The truth is there is a challenge. However, we are not hopeless. The COVAX facility is not the only one we rely on. There is also AVATT, the regional facility which is the African Vaccine Acquisition Task Team. So, we definitely will be looking to AVATT to help increase the initial allocation in the circumstances with what is happening vis-a-vis production and supply from India.

“Both AVATT and COVAX are multilateral facilitators, but we also have bilateral negotiations. For example, the Sputnik is bilateral in the sense that it is government to government. Sputnik is Russian and as soon as we have the dossier and approval from NAFDAC, then we will consider it.”

Mamora stated that the Federal Government might have to increase its budget for vaccines since AstraZeneca, which is the cheapest in the market, is not readily available.

He said, “One of the reasons we settled for AstraZeneca is not just because it is cheap but is as good as the others. They are giving it out at cost value. The challenge is that the initial element in terms of cost projection would have to increase because AstraZeneca is the cheapest. So, we may have to reconsider our initial cost projection. That is the challenge I see.”

The Federal Government had received 3.9 million doses of the AstraZeneca vaccines through COVAX, a global initiative co-led by the Global Vaccine Alliance, Coalition for Epidemic Preparedness Innovations and World Health Organisation. The initiative was designed to ensure fair and equitable access for every country.

The vaccine arrived in Nigeria on March 2, 2021 while in the second week of March the government began distribution to states, except Kogi, whose governor, Yahaya Bello, had described COVID-19 as glorified malaria.

Persons who opt for AstraZeneca vaccines must take two doses which are usually administered at least two months apart. It was learnt that Ekiti, Bauchi and Kwara states had already administered half of their vaccine supply and had complied with the government’s directive to halt further roll-out.

Meanwhile, the Chairman, Bauchi State Primary Health Care Development Agency and Contacts and Surveillance Sub-Committee Chairman, Bauchi State Task Force on COVID-19, Dr Rilwan Mohammed, told Sunday PUNCH that the Executive Director, NPHCDA, Dr Faisal Shuaibu, wrote to Commissioners for Health in the states to suspend vaccination so that people who had received the first jab could get the second one.

Mohammed stated that Bauchi State was given 89,570 doses but had to stop administering the vaccines immediately after it received the letter having administered about half already. “We have 32,000 coverage but the call-up data is actually 41,000 just that we are still uploading to the national site because of network problems,” he added.

He stated, “There is a shortage of supply of the COVID-19 vaccine, and the Executive Director of the National Primary Health Care Development Agency, Dr Faisal Shuaibu, wrote to all the states that we should suspend vaccination when we reach half of the doses we got.

“The Federal Government realised that within eight to 12 weeks, you must be able to give the second dose but if there is no second dose to give, that means we have wasted the first dose, so they told us to stop if we have reached halfway.

“There is a crisis in the AstraZeneca production. India is having COVID-19 mutation in their country, so they decided to allocate more doses to themselves before exporting it. Secondly, the European Union which initially claimed that the vaccine had some issues has now come back after they found out that the vaccine is okay and they had made a forward request.”

Nevertheless, he explained that the state had set aside a small portion of the vaccine for intending pilgrims because vaccination had become a requirement for those visiting holy cities.

He added, “There are 4,000 Muslim pilgrims, meaning we would need 8,000 doses for them, while there are 170 Christian pilgrims, meaning we would need 340 doses for them, including their staff.

“We have a complaint from the Hajj and Christian commissions and Jerusalem and Saudi authorities have given an order that all those coming for pilgrimage and their staff must show evidence of COVID-19 test and vaccination (first and second doses).”

He said he would write to the Executive Director of NPHCDA to request for vaccines to be administered on the pilgrims.

Mohammed said there had only been 145 reactions – mostly mild – out of the tens of thousands vaccinated in the state so far, noting that the rule that sick persons should not be vaccinated had saved the state from controversies.

He added, “We have only 145 reactions due to COVID-19 vaccine and most of them are mild. Somebody went to our vaccination post in Darazo but unfortunately he was ill, so we told him that one of the conditions was that if you were sick we wouldn’t be able to give you a vaccine. The next day, he died. If we had allowed him to be vaccinated, people would say it was due to COVID-19 vaccination.”

He ruled out the possibility of the state going to look for a vaccine on its own, noting that it was best to use the one already certified by NAFDAC and that there was already a strategic plan for vaccination roll-out in the country.

Asked when the vaccination would resume, he said they had been told to start administering the second dose from May 24 because the vaccine would expire in June, since every batch has its expiry date.

Benue stops vaccination

Meanwhile, the Benue State Government says it has suspended the vaccination exercise, in line with the caution from the Executive Director, NPHCDA.

The state Commissioner for Health, Dr Joseph Ngbea, told one of our correspondents on the telephone on Friday that the state had stopped vaccination, though it did not make a formal announcement.

Ngbea said, “Yes, we have stopped the vaccination of people but we did not announce it, although there are a few people looking to be vaccinated. For example, on Thursday, we still vaccinated one of the former governors of the state who demanded for it. Unlike when we were encouraging people to come out and take the vaccine, we have stopped that.

“We had a meeting with the Executive Director of National Primary Health Care Development Agency who cautioned us to stop giving out the vaccine because of the Indian ban on export of the vaccine.”

Loading

Health

FG expands emergency healthcare services to 34 states

Published

on

FG expands emergency healthcare services to 34 states
Minister of State for Health and Social Welfare, Dr. Iziaq Salako

FG expands emergency healthcare services to 34 states

The Federal Government (FG) has expanded the National Emergency Medical Service and Ambulance System (NEMSAS) to 34 states, in a major push to improve emergency healthcare, strengthen intensive and critical care services, and accelerate progress towards Universal Health Coverage (UHC) across Nigeria.

The expansion was announced by the Minister of State for Health and Social Welfare, Dr. Iziaq Salako, during the opening of the 11th Annual Scientific Conference and Annual General Meeting of the Intensive and Critical Care Society of Nigeria (I-CCSN) in Abuja.

Speaking on the conference theme, “Sustainable Financing for Intensive Care in Public Hospitals in Nigeria,” Salako described emergency and intensive care as essential pillars of a resilient healthcare system, saying timely access to quality treatment saves lives, reduces preventable deaths and protects families from the devastating financial impact of critical illnesses.

According to a statement issued by the ministry’s Assistant Director of Information and Public Relations, Ado Bako, the minister said the expansion of NEMSAS from its pilot phase in the Federal Capital Territory (FCT) to 34 states represents one of the Federal Government’s flagship health sector reforms, with efforts already underway to extend the programme to all 36 states and the FCT.

The National Emergency Medical Service and Ambulance System (NEMSAS) was established to provide a coordinated national emergency response by ensuring the rapid evacuation and transportation of critically ill or injured patients to appropriate healthcare facilities. The initiative supports victims of road traffic crashes, maternal emergencies, medical complications, disasters and other life-threatening situations that require urgent intervention.

READ ALSO:

Salako said the Tinubu administration considers emergency and critical care a strategic investment in Nigeria’s healthcare system, noting that improved emergency response capacity is critical to achieving better health outcomes, strengthening national health security and reducing avoidable deaths.

He observed that delivering quality intensive care requires sustained investments in specialised infrastructure, fully equipped ambulances, intensive care units (ICUs), trauma centres, medical oxygen systems, modern diagnostic equipment, reliable electricity supply and highly trained healthcare professionals.

The minister also expressed concern over Nigeria’s continued dependence on out-of-pocket healthcare spending, warning that many households are forced into financial hardship because of the high cost of emergency treatment and intensive care.

To reduce this burden, he said the Federal Government is expanding health insurance coverage, strengthening sustainable healthcare financing and implementing reforms aimed at making emergency medical services more accessible and affordable.

According to Salako, the government is simultaneously implementing complementary programmes to improve maternal and newborn healthcare, strengthen referral systems and integrate ambulance services with intensive care units, operating theatres, rehabilitation centres and medical oxygen supply networks.

He added that lessons from the COVID-19 pandemic have prompted increased investment in medical oxygen infrastructure, with Pressure Swing Adsorption (PSA) oxygen plants already installed in several federal and state health facilities to improve oxygen availability for critically ill patients.

The minister further disclosed that the government is promoting digital health technologies, telemedicine and tele-critical care services to bridge gaps in access to specialist healthcare, particularly in underserved and rural communities.

Salako emphasised that achieving sustainable emergency healthcare requires stronger collaboration among the Federal Government, state governments, healthcare institutions, professional associations, academic and research institutions, development partners, civil society organisations and the private sector.

He also called for greater investment in healthcare workforce development through the training of more intensive care physicians, emergency medicine specialists, nurses, physiotherapists, pharmacists, anaesthetists, biomedical engineers and other specialised healthcare professionals.

The minister said these reforms align with the Nigeria Health Sector Renewal Investment Initiative and other ongoing efforts to strengthen primary healthcare, emergency medical services and referral systems nationwide.

Earlier, Chairman of the Conference Local Organising Committee, Dr. Harrison Nwogu, said participants would examine the persistent underfunding of intensive care units and explore innovative financing mechanisms, including public-private partnerships (PPPs), expanded health insurance, philanthropic support and diaspora investment.

Chairman of the occasion and Chief Medical Director of Zenith Medical and Kidney Centre, Dr. Olalekan Olutesi, urged wealthy Nigerians and corporate organisations to invest more in the health sector, suggesting tax incentives to encourage greater private-sector participation in healthcare delivery.

Delivering the keynote address, Professor Tamuno-Ojuemi Ogaji advocated a sustainable financing framework that guarantees access to quality intensive care regardless of a patient’s financial status.

He identified inadequate infrastructure, shortages of medical equipment and consumables, unstable electricity supply, limited intensive care beds and insufficient funding as some of the major obstacles affecting critical care delivery in Nigeria.

Also speaking, the Emir of Wase, Dr. Muhammadu Haruna, who represented the Emir of Tula, Dr. Abubakar Buba, described intensive care as a national development issue that affects every Nigerian family.

He said strengthening emergency and critical care services would improve survival rates, reduce preventable deaths and contribute significantly to Nigeria’s economic and social development.

The Federal Government expressed confidence that the continued expansion of NEMSAS, improved healthcare financing, stronger referral systems and sustained investments in emergency medical infrastructure would significantly improve access to life-saving care and strengthen Nigeria’s overall healthcare system.

FG expands emergency healthcare services to 34 states

Loading

Continue Reading

Health

Tinubu approves new health technology agency to modernise Nigeria’s healthcare system

Published

on

FG Clears N39.6bn Pension Arrears for Former NITEL, PHCN, Bank Workers

Tinubu approves new health technology agency to modernise Nigeria’s healthcare system

President Bola Tinubu has approved the establishment of the National Health Technology and Data Analytics Office (NHTDAO), a landmark initiative aimed at accelerating the digital transformation of Nigeria’s healthcare system through innovation, data-driven decision-making and improved coordination across the health sector.

The Presidency also announced the appointment of Dr. Obi Adigwe, a respected pharmaceutical researcher and health innovation expert, as the pioneer National Coordinator of the newly created office.

The development was disclosed in a statement issued by the Special Adviser to the President on Information and Strategy, Bayo Onanuga, who said the new agency would operate under the Office of the Coordinating Minister of Health and Social Welfare.

According to the Presidency, the NHTDAO will serve as a central coordinating platform for health technology, digital health systems and data analytics, helping to unify public and private healthcare institutions without taking over the statutory responsibilities of existing agencies.

Rather than replacing institutions already operating within the health sector, the office will strengthen collaboration among federal and state governments, healthcare providers, development partners and regulatory bodies while promoting the adoption of modern digital healthcare solutions nationwide.

The statement explained that the office would harmonise healthcare institutions, establish national interoperability standards and oversee the implementation of the National Digital Health Architecture, which was approved by the National Council on Health in November 2025.

READ ALSO:

The initiative is expected to accelerate the deployment of electronic medical records, improve healthcare data management, strengthen disease surveillance systems and support evidence-based policymaking across Nigeria’s health sector.

Government officials believe the new office will also improve emergency response capabilities, facilitate secure information sharing among healthcare institutions and enhance transparency, accountability and efficiency in healthcare delivery.

The Presidency said the creation of the agency aligns with President Tinubu’s commitment to building a secure, technology-driven and data-enabled healthcare system capable of delivering quality medical services to Nigerians under the administration’s Renewed Hope Agenda.

The appointment of Dr. Obi Adigwe is expected to provide strong leadership for the initiative, given his extensive experience in pharmaceutical research, digital health innovation and healthcare policy.

Before his appointment, Adigwe served as Director-General of the National Institute for Pharmaceutical Research and Development (NIPRD), where he led several groundbreaking initiatives to strengthen Nigeria’s pharmaceutical and biomedical research capacity.

His achievements include managing a ¥300 million nanotechnology research grant, overseeing an AFREXIMBank-funded project that established Africa’s first Active Pharmaceutical Ingredients (API) Training Facility and coordinating the roadmap that secured an €18 million European Union grant to support Nigeria’s pharmaceutical industry.

Adigwe also gained international recognition during the COVID-19 pandemic after leading the world’s first scientific evaluation that challenged claims surrounding the effectiveness of Madagascar’s Covid Organics herbal preparation.

To ensure effective implementation and policy coordination, the Federal Government has constituted a high-level steering committee to oversee the activities of the National Health Technology and Data Analytics Office.

The committee will be co-chaired by the Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, and the Chairman of the Nigerian Economic Summit Group, Olaniyi Yusuf.

Its membership also includes the Minister of State for Health and Social Welfare, the Special Adviser to the President on Technology and Digital Economy, the heads of the National Primary Health Care Development Agency (NPHCDA), the National Health Insurance Authority (NHIA), the National Information Technology Development Agency (NITDA), as well as six representatives of State Commissioners of Health from Nigeria’s six geopolitical zones.

The steering committee is expected to provide strategic guidance, monitor implementation and ensure that digital health reforms are effectively integrated across the country’s healthcare ecosystem.

The establishment of the NHTDAO complements ongoing reforms under the Nigeria Health Sector Renewal Investment Initiative, which seeks to strengthen primary healthcare services, improve access to quality medical care, expand emergency health services and modernise healthcare infrastructure across the country.

Health policy experts say the initiative could significantly transform Nigeria’s healthcare system by improving health data management, promoting innovation, strengthening policy coordination and enabling more efficient healthcare delivery nationwide.

The Presidency expressed confidence that the new office would accelerate Nigeria’s transition to a secure, interoperable and data-driven healthcare ecosystem capable of improving health outcomes for millions of citizens.

Tinubu approves new health technology agency to modernise Nigeria’s healthcare system

Loading

Continue Reading

Health

AI Smartphone App Detects Eye Cancer with Near-Specialist Accuracy, Study Finds

Published

on

AI Smartphone App Detects Eye Cancer with Near-Specialist Accuracy, Study Finds

AI Smartphone App Detects Eye Cancer with Near-Specialist Accuracy, Study Finds

A smartphone-based Artificial Intelligence (AI) application has demonstrated the ability to detect cancers on the surface of the eye with near-specialist accuracy, offering hope for faster diagnosis and improved access to care for patients with potentially sight-threatening and life-threatening conditions.

The application, known as Capture-Tumor, uses advanced deep-learning technology to analyze photographs of the eye taken with a smartphone and identify signs of ocular surface malignancies. Researchers say the innovation could transform early cancer detection by enabling users to perform initial screenings from home before being referred to specialist care.

The findings were published in JAMA Ophthalmology following a non-randomized clinical trial led by researchers at Sun Yat-sen University, China, who evaluated the system’s effectiveness in real-world settings.

According to the researchers, the AI model was trained using more than 12 years of specialist ophthalmic images collected by eye care professionals. The system was initially developed using slit-lamp photographs taken in hospitals before being adapted to work with standard smartphone images captured by patients themselves.

The app includes built-in image-quality assessment tools and provides real-time instructions to help users take suitable photographs. Once captured, images are uploaded to a cloud-based platform where the AI analyzes them and flags suspicious lesions that may require specialist review.

The study involved 614 participants aged between four and 87 years, with a median age of 46. Participants were recruited through television campaigns, social media platforms and online hospital portals. Researchers analyzed 805 eye images from 535 participants included in the final assessment.

READ ALSO:

To ensure diagnostic accuracy, images were matched against histopathological findings where available. In cases where tissue diagnosis was not possible, clinical examinations and telemedicine reviews were used to establish final diagnoses.

The primary objective was to determine how effectively the AI system could distinguish between malignant and benign eye surface lesions.

Results showed impressive performance. During controlled testing using specialist clinical images, the model achieved an Area Under the Curve (AUC) score of 0.945, indicating a high level of diagnostic accuracy. When deployed in real-world conditions using smartphone photographs and in-app guidance, performance improved further, reaching an AUC of 0.977.

The system recorded a sensitivity rate of 89.3 percent, meaning it correctly identified most cancer cases, while its specificity reached 95.9 percent, demonstrating a strong ability to rule out non-cancerous conditions.

One of the study’s most significant findings was the app’s ability to identify previously undiagnosed cancers.

The AI platform generated 58 referrals to specialist centers, resulting in the confirmation of 20 malignant cases through histopathological examination. Remarkably, 19 of those cancers had not been previously diagnosed, highlighting the technology’s potential role in detecting disease earlier than traditional referral pathways.

Researchers noted that none of the newly diagnosed patients required removal of the eye or surrounding orbital tissue, suggesting that earlier intervention may have contributed to more favorable treatment outcomes.

The study also found that the app significantly streamlined access to specialist care. Before using the AI system, patients required an average of 3.69 referrals before reaching definitive treatment. Following implementation of the technology, that figure dropped dramatically to just 1.02 referrals, representing a major improvement in efficiency and patient access.

READ ALSO:

Experts believe this could reduce delays that often occur when patients move between multiple healthcare providers before receiving an accurate diagnosis.

The researchers further suggested that widespread adoption of smartphone-based screening could substantially increase the number of eye cancer cases detected and treated at specialist centers. However, they cautioned that these projections require additional validation through larger studies.

An accompanying editorial described Capture-Tumor as a pioneering “closed-loop” healthcare model that combines public awareness, AI-assisted screening, specialist triage and targeted referrals within a single platform.

Experts said the study provides an important proof of concept for using AI and mobile technology to decentralize screening for rare diseases, particularly in regions where access to specialist ophthalmologists remains limited.

Eye surface cancers, collectively known as ocular surface squamous neoplasia (OSSN) and related malignancies, can be difficult to diagnose in their early stages because symptoms often resemble less serious eye conditions. Delayed diagnosis can lead to vision impairment, extensive surgery and, in severe cases, cancer spread.

The emergence of smartphone-based AI screening tools could therefore play a critical role in reducing diagnostic delays and improving patient outcomes, especially in low-resource settings where specialist care is scarce.

Despite the promising findings, researchers acknowledged several limitations. Most participants were of Chinese origin, meaning further studies are needed to determine how well the technology performs across diverse ethnic and geographic populations. They also noted that older users may face challenges using smartphone-based screening tools and that the study primarily assessed short-term diagnostic outcomes rather than long-term clinical benefits.

The team emphasized that the application is intended to support—not replace—medical professionals. Any suspicious findings identified by the app would still require confirmation through clinical examination and specialist evaluation.

As healthcare systems increasingly adopt AI-powered diagnostic tools, experts say technologies such as Capture-Tumor could help bridge gaps in access to specialist care, improve early cancer detection and potentially save sight and lives through timely intervention.

AI Smartphone App Detects Eye Cancer with Near-Specialist Accuracy, Study Finds

Loading

Continue Reading

Trending